These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 12559126
1. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Castro M, Diaz A, del Olmo E, Pazos A. Neuropharmacology; 2003 Jan; 44(1):93-101. PubMed ID: 12559126 [Abstract] [Full Text] [Related]
2. Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography. Pejchal T, Foley MA, Kosofsky BE, Waeber C. Br J Pharmacol; 2002 Mar; 135(5):1115-22. PubMed ID: 11877317 [Abstract] [Full Text] [Related]
3. Regulation of 5-HT(1A) receptor-stimulated [35S]-GtpgammaS binding as measured by quantitative autoradiography following chronic agonist administration. Hensler J, Durgam H. Br J Pharmacol; 2001 Jan; 132(2):605-11. PubMed ID: 11159711 [Abstract] [Full Text] [Related]
4. Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins. Moulin-Sallanon M, Charnay Y, Ginovart N, Perret P, Lanfumey L, Hamon M, Hen R, Fagret D, Ibáñez V, Millet P. Synapse; 2009 Feb; 63(2):106-16. PubMed ID: 19016488 [Abstract] [Full Text] [Related]
5. WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality. Castro E, Díaz A, Rodriguez-Gaztelumendi A, Del Olmo E, Pazos A. Neuropharmacology; 2008 Dec; 55(8):1391-6. PubMed ID: 18809415 [Abstract] [Full Text] [Related]
6. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency. Meller E, Li H, Carr KD, Hiller JM. J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306 [Abstract] [Full Text] [Related]
10. Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration. Hensler JG. Neuropsychopharmacology; 2002 May; 26(5):565-73. PubMed ID: 11927181 [Abstract] [Full Text] [Related]
11. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine. Rasmussen K, Calligaro DO, Czachura JF, Dreshfield-Ahmad LJ, Evans DC, Hemrick-Luecke SK, Kallman MJ, Kendrick WT, Leander JD, Nelson DL, Overshiner CD, Wainscott DB, Wolff MC, Wong DT, Branchek TA, Zgombick JM, Xu YC. J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249 [Abstract] [Full Text] [Related]
12. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR. Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388 [Abstract] [Full Text] [Related]
13. A chronic treatment with fluoxetine decreases 5-HT(1A) receptors labeling in mice selected as a genetic model of helplessness. Naudon L, El Yacoubi M, Vaugeois JM, Leroux-Nicollet I, Costentin J. Brain Res; 2002 May 17; 936(1-2):68-75. PubMed ID: 11988231 [Abstract] [Full Text] [Related]
14. Sustained desensitization of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited neuroendocrine responses to 8-hydroxy-2-(Dipropylamino)Tetralin in the absence of changes in Gi/o/z proteins. Raap DK, Garcia F, Muma NA, Wolf WA, Battaglia G, van de Kar LD. J Pharmacol Exp Ther; 1999 Feb 17; 288(2):561-7. PubMed ID: 9918559 [Abstract] [Full Text] [Related]
15. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine. Freo U, Merico A, Ermani M, Ori C. Brain Res; 2010 Jun 04; 1335():24-34. PubMed ID: 20381465 [Abstract] [Full Text] [Related]
16. Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies. Sprouse J, Braselton J, Reynolds L, Clarke T, Rollema H. Synapse; 2001 Jul 04; 41(1):49-57. PubMed ID: 11354013 [Abstract] [Full Text] [Related]
17. Displacement of the binding of 5-HT(1A) receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain. Raurich A, Mengod G, Artigas F, Cortés R. Synapse; 1999 Oct 04; 34(1):68-76. PubMed ID: 10459173 [Abstract] [Full Text] [Related]
18. Rapid desensitization of 5-HT(1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment. Kantor S, Graf M, Anheuer ZE, Bagdy G. Eur Neuropsychopharmacol; 2001 Feb 04; 11(1):15-24. PubMed ID: 11226808 [Abstract] [Full Text] [Related]
19. Pindolol antagonises G-protein activation at both pre- and postsynaptic serotonin 5-HT1A receptors: a. Newman-Tancredi A, Chaput C, Touzard M, Millan MJ. Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr 04; 363(4):391-8. PubMed ID: 11330332 [Abstract] [Full Text] [Related]
20. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Le Poul E, Laaris N, Doucet E, Laporte AM, Hamon M, Lanfumey L. Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug 04; 352(2):141-8. PubMed ID: 7477436 [Abstract] [Full Text] [Related] Page: [Next] [New Search]